Calcitonin Gene-Related Peptide (CGRP) Antagonists

DBCAT004663Therapeutic categoryN02CD

A DrugBank category of 8 drugs. 8 of them are approved.

ATC classification: N — NERVOUS SYSTEM
N02 — ANALGESICS
N02C — ANTIMIGRAINE PREPARATIONS
N02CD — Calcitonin gene-related peptide (CGRP) antagonists
Also known as: Calcitonin-gene-related peptide (CGRP) antagonists
Drugs: Atogepant
Eptinezumab
Erenumab
Fremanezumab
Galcanezumab
Rimegepant
Ubrogepant
Zavegepant

What you can answer from here — as of September 21, 2021

8DrugsEach linked to its full drug card

Listed above

4Drug targetsEvery drug–target pair in the class, with bond type

120Marketed productsAcross the regions we cover, with dosage forms and routes

6Routes of administrationHow the drugs in this class are given

Which targets do Calcitonin Gene-Related Peptide (CGRP) Antagonists share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.